Momenta Pharmaceuticals, Inc. (MNTA)

[DewDiligence]

Amended NVS-MNTA Lovenox agreement, calling for 50/50 profit split instead of a royalty:

http://www.sec.gov/Archives/edgar/data/1235010/000110465915046306/a15-14315_1ex10d1.htm

This change will be economically material to MNTA only if NVS/MNTA ultimately prevail in the Lovenox patent case by circumventing the H-W Safe Harbor defense.